( April 27, 2026, 2:15 PM EDT) -- WASHINGTON, D.C. — The D.C. Circuit U.S. Court of Appeals on April 24 ordered an expedited briefing schedule of a California-based e-liquid manufacturer’s petition for review of a Food and Drug Administration ban of its products, which the court previously declined to stay and which the company claims will hurt its business and cause it irreparable harm....